Daniel Carradice

Vascular Surgeon @HullHospitals
Professor @HullYorkMed
Vasc Surgical Specialty Lead @RCSnews
Chair Venous Special Interest Group @VSGBI
Tweets my opinions

[VERN @VascResearchNet]

The REPAIR Survey is OPEN now! 🚨🚨🚨

Is cardiopulmonary exercise testing (CPET) used to aid clinical decision making when planning elective AAA repair? Let's find out! @vasgbi

Collaborative authorship available for all participants!

https://t.co/RFE0fTGURs

[Daniel Carradice @DanielCarradice]

An honour and a privilege. Thank you for the kind invitation to address the Royal Society of Medicine.

[RSM Venous Forum @ForumRsm]

Great professorial talk from @DanielCarradice #rsmvf2026

[Daniel Carradice @DanielCarradice]

A great meeting. Good to catch up with everyone. Can't wait to see the change we can drive as a community.

[Zola Mzimba @veinsnorthwest]

Venous Forum @RoyalSocMed — a brilliant meeting. Standout moment: Prof Dan Carradice calling it plainly — patients with venous disease are being failed. By the health service. By those providing their care. It’s time for that to change. #VenousDisease #Phlebology

[Daniel Carradice @DanielCarradice]

Very well written by outstanding minds.

[Athanasios Saratzis @a_saratzis]

Editorial on @EJVES_ESVS 👉what do we mean when we conclude that a "fully powered randomised trial" is needed? Are all RCTs the same?

https://t.co/L31ER3Biqs

[Dr Zubir Ahmed MP @zubirahmed]

𝗜 𝗵𝗮𝗱 𝘁𝗼 𝘁𝘂𝗿𝗻 𝗱𝗼𝘄𝗻 𝗮𝗻 𝗼𝗿𝗴𝗮𝗻 𝗱𝗼𝗻𝗮𝘁𝗶𝗼𝗻 because we couldn’t access GP records at the weekend.

That should never happen in a modern NHS.

Labour built the NHS in difficult times. Now, in difficult times once again, we must be bold enough to modernise it.

We cannot afford to keep looking the other way.

We must go big on giving patients more control, go big on embracing technology, and go big on building an NHS fit for the future.

Patients deserve better. NHS staff deserve better. The technology exists.

Now we need the courage to act.

[Daniel Carradice @DanielCarradice]

The UK is a temperate country. For the last 150 years the average max temp in May is 15 degrees....
Climate change is a hoax they said, drill baby drill they said.
No. It is time to make the changes today that our children and grandchildren need for tomorrow.

[Circulation Foundation @CircFoundation]

🔦 Lights.

🎥 Camera.

🎬 Action!

🤝We are excited to be working with Natcho Creative on a short film to raise awareness of peripheral artery disease. #PAD

🎞️Filming has begun! Here’s a sneak peak.

👀Watch this space for more….

[HSJ Awards @HSJ_Awards]

For an approach that embodies precisely what prevention-focused digital innovation should look like across the NHS, @NHSHHP are the winners of Driving Prevention and Early Intervention through Digital award!

Well done!

#HSJDigitalAwards

[Athanasios Saratzis @a_saratzis]

1st newsletter for the @NIHRresearch RAVE RCT: lithotripsy vs. no lithotripsy in calcified #PAD lesions - take part now!

[frank arko @farkomd]

Bringing the data. The trials vascular surgery needs

[Daniel Carradice @DanielCarradice]

Outstanding recognition for our Vascular AI research programme led by the extraordinary talent of @bharathtiger I can't wait to see the exciting future we are building and always look forward to plotting the next move over a local real ale in my little Village in the Wolds.

[Bharat Ravindhran @bharathtiger]

Thank you @HSJ_Awards for the recognition! @VascularHull ,@chetter_ian ,@DanielCarradice,@seanpymer9 ,@prof_thakker

[Daniel Carradice @DanielCarradice]

Please get on board EARLY, these are really exciting opportunities to drive knowledge and improvements in patient outcomes. Push your R&D, get the trials open, recruit hard, be the light which illuminates a brighter future for our patients and our specialty

[Athanasios Saratzis @a_saratzis]

1st newsletter for the @NIHRresearch RAVE RCT: lithotripsy vs. no lithotripsy in calcified #PAD lesions - take part now!

[Daniel Carradice @DanielCarradice]

Imagine where we would be if we had spent these years trying to understand rather than refute what the data were telling us. We really need to focus on new knowledge and technology to manage the post endovascular blood-vessel interface.

[ESVS @ESVSmembership]

🔍 Focused update - ESVS PAD Guidelines

Recently published high-quality evidence, particularly the SWEDEPAD 2 trial, showed no meaningful quality-of-life benefit and raised concerns about possible long-term mortality with paclitaxel-coated devices, challenging prior assumptions about their net benefit. This prompted a focused update given the potential direct impact on patient safety and clinical decision-making in patients with intermittent claudication

Read the article here: https://t.co/pwXuCmDhiQ

@robhinchliffe1 @AWanhainen @VASCevidence

[Vascular and Venous All-Party Parliamentary Group @VAPPG]

If you came to the event today, do share your pictures below…

[Daniel Carradice @DanielCarradice]

@farkomd @jmills1955 Maybe just open the NIHR RAF trial with @a_saratzis 😀

[Daniel Carradice @DanielCarradice]

Great to see this level of support and enthusiasm for building future leaders.

[frank arko @farkomd]

Big moment for our program.

Thrilled to welcome three outstanding vascular surgery fellows to Carolinas Medical Center for 2027–2029. The growth reflects the strength of our training environment, mentorship, and case volume.

The future is being built now.

[VERN @VascResearchNet]

We are so close to the finish line.

If you’re at @CXSymposium this week, please take a few minutes to complete the survey, we really want to hear from vascular scientists and sonographers.

It only takes a few minutes and please spread around your colleagues at @CXSymposium 👇

[Daniel Carradice @DanielCarradice]

Check out this video introducing the NIHR ESTABLISH Trial. VRUK interviews @SandipNandhra
The Chief Investigator. Please support this study and she'd light on the management of Acute Limb Ischaemia.
@a_saratzis @VSGBI @BSIR_News
@NIHRresearch @LegsMatter https://t.co/nUEms22cPC

[Vascular News @VascularNews]

David Bosanquet and Matthew Popplewell speak to @vascularnews about the goals and scope of the ROSSINI-Platform trial, encouraging fellow specialists to take part @davebosanquet @MAPopplewell https://t.co/hT1gfqWCQu

[Leanne Atkin (PhD MHSc RGN) @Leannejane1975]

Check out our new publication from the @LegsMatter team - without data we will never be able to change the system! https://t.co/3GpNL9aI0x